Utilization of supportive care medications and opportunities for pre-emptive pharmacogenomic testing in pediatric and young adults with leukemia-Reference-Cited by-同舟云学术

Utilization of supportive care medications and opportunities for pre-emptive pharmacogenomic testing in pediatric and young adults with leukemia

Author:

Sakon Colleen M.¹,Sales Carmina²,Mertami Selsbiel³,Raibulet Andra⁴,Schulte Rachael R.⁵,Slaven James E.⁶,Tillman Emma M.³

Affiliation:

1. Indiana University Health, Indianapolis, Indiana, USA

2. Purdue University College of Pharmacy, Purdue University, West Lafayette, Indiana, USA

3. Division of Clinical Pharmacology, Indiana University School of Medicine (IUSM), Indianapolis, Indiana, USA

4. College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana, USA

5. Department of Pediatrics, Division of Pediatric Hematology/Oncology/Stem Cell Transplant, IUSM, Indianapolis, Indiana, USA

6. Department of Biostatistics and Health Data Science, IUSM, Indianapolis, Indiana, USA

Funder

supported by NIH

Indiana University Melvin and Bren Simon Cancer Center Support Grant

Publisher

Informa UK Limited

Link

Reference21 articles.

2. Childhood Leukemia – Cancer Stat Facts. SEER. Accessed October 14 2023. https://seer.cancer.gov/statfacts/html/childleuk.html.